AFP and hepatocellular carcinoma: Used as a diagnostic biomarker and a potential therapeutic target in HCC. Low expression of FTCD is closely related to the poor prognosis, alpha‐fetoprotein (AFP) level, larger tumour size and vascular invasion of HCC